367 related articles for article (PubMed ID: 3142490)
1. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
Nagao S; Sato K; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
[TBL] [Abstract][Full Text] [Related]
2. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
Nagao S; Sato K; Osada Y
Jpn J Cancer Res; 1987 Jan; 78(1):80-6. PubMed ID: 3102442
[TBL] [Abstract][Full Text] [Related]
3. Specific binding sites of muroctasin on murine macrophages.
Akasaki M; Masayasu H; Tsukada W; Takegoshi T
Arzneimittelforschung; 1988 Jul; 38(7A):978-80. PubMed ID: 3190804
[TBL] [Abstract][Full Text] [Related]
4. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
Saiki I; Fidler IJ
J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
[TBL] [Abstract][Full Text] [Related]
5. Production of colony-stimulating factor from macrophages by muroctasin.
Yamaguchi F; Akahane K; Takashi T; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
[TBL] [Abstract][Full Text] [Related]
6. Activation of immune responses by muroctasin.
Akasaki M
Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
[TBL] [Abstract][Full Text] [Related]
7. Local tolerance of muroctasin injection in rabbits.
Nakashima K; Jindo T; Nomura M
Arzneimittelforschung; 1988 Jul; 38(7A):1038-9. PubMed ID: 3190798
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo augmentation by muroctasin of the production of the third component of complement by murine macrophages.
Endo N
Arzneimittelforschung; 1988 Jul; 38(7A):993-6. PubMed ID: 3190805
[TBL] [Abstract][Full Text] [Related]
9. Mutagenicity studies of muroctasin.
Shimada H; Hattori C; Sato T
Arzneimittelforschung; 1988 Jul; 38(7A):1031-3. PubMed ID: 3056424
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of macrophages by muroctasin to produce colony-stimulating factors.
Akahane K; Yamaguchi F; Kita Y; Une T; Osada Y
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):179-83. PubMed ID: 1692219
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of non-specific resistance to infection by muroctasin.
Otani T; Une T; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):969-76. PubMed ID: 3056426
[TBL] [Abstract][Full Text] [Related]
12. Studies on the stability of muroctasin and degradation products built under extreme conditions.
Moroi R; Yamazaki K; Hirota T; Watanabe S; Oki M; Toriyama M; Ichinohe A; Kataoka K
Arzneimittelforschung; 1988 Jul; 38(7A):959-68. PubMed ID: 3190803
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
[TBL] [Abstract][Full Text] [Related]
14. Subacute toxicity of muroctasin in mice and dogs.
Ono Y; Iwasaki T; Sekiguchi M; Onodera T
Arzneimittelforschung; 1988 Jul; 38(7A):1024-7. PubMed ID: 3190795
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of plasma fibronectin production in mice by muroctasin.
Endo N; Okuda T; Osada Y; Zen-Yoji H
Arzneimittelforschung; 1988 Jul; 38(7A):997-8. PubMed ID: 3190806
[TBL] [Abstract][Full Text] [Related]
16. Chronic toxicity of muroctasin in mice.
Ono Y; Sekiguchi M; Aihara K; Onodera T
Arzneimittelforschung; 1988 Jul; 38(7A):1028-30. PubMed ID: 3190796
[TBL] [Abstract][Full Text] [Related]
17. [Muroctasin, a muramyl dipeptide derivative].
Sosnowska D; Dzierzbicka K; Myśliwski A; Kołodziejczyk AM
Postepy Hig Med Dosw; 1992; 46(5):521-30. PubMed ID: 1298958
[TBL] [Abstract][Full Text] [Related]
18. Potential adjuvants for synthetic vaccines. I. Modulators of macrophage activation.
Solange A
Chem Phys Lipids; 1995 Jan; 75(1):51-8. PubMed ID: 7697782
[TBL] [Abstract][Full Text] [Related]
19. Elevation by muroctasin of the serum level of the complement subcomponent C1q in mice and of its biosynthesis by cultured mouse peritoneal macrophages.
Endo N; Okuda T; Osada Y; Zen-yoji H
Arzneimittelforschung; 1990 Jan; 40(1):58-61. PubMed ID: 2340001
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of muroctasin in mice.
Matsubayashi K; Takegoshi T
Arzneimittelforschung; 1988 Jul; 38(7A):1015-8. PubMed ID: 3190793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]